Literature DB >> 19717847

Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis.

Rutger J van Bommel1, Jeroen J Bax, William T Abraham, Eugene S Chung, Luis A Pires, Luigi Tavazzi, Peter J Zimetbaum, Bart Gerritse, Nina Kristiansen, Stefano Ghio.   

Abstract

AIMS: Predictors of Response to Cardiac Resynchronization Therapy (CRT) (PROSPECT) was the first large-scale, multicentre clinical trial that evaluated the ability of several echocardiographic measures of mechanical dyssynchrony to predict response to CRT. Since response to CRT may be defined as a spectrum and likely influenced by many factors, this sub-analysis aimed to investigate the relationship between baseline characteristics and measures of response to CRT. METHODS AND
RESULTS: A total of 286 patients were grouped according to relative reduction in left ventricular end-systolic volume (LVESV) after 6 months of CRT: super-responders (reduction in LVESV > or =30%), responders (reduction in LVESV 15-29%), non-responders (reduction in LVESV 0-14%), and negative responders (increase in LVESV). In addition, three subgroups were formed according to clinical and/or echocardiographic response: +/+ responders (clinical improvement and a reduction in LVESV > or =15%), +/- responders (clinical improvement or a reduction in LVESV > or =15%), and -/- responders (no clinical improvement and no reduction in LVESV > or =15%). Differences in clinical and echocardiographic baseline characteristics between these subgroups were analysed. Super-responders were more frequently females, had non-ischaemic heart failure (HF), and had a wider QRS complex and more extensive mechanical dyssynchrony at baseline. Conversely, negative responders were more frequently in New York Heart Association class IV and had a history of ventricular tachycardia (VT). Combined positive responders after CRT (+/+ responders) had more non-ischaemic aetiology, more extensive mechanical dyssynchrony at baseline, and no history of VT.
CONCLUSION: Sub-analysis of data from PROSPECT showed that gender, aetiology of HF, QRS duration, severity of HF, a history of VT, and the presence of baseline mechanical dyssynchrony influence clinical and/or LV reverse remodelling after CRT. Although integration of information about these characteristics would improve patient selection and counselling for CRT, further randomized controlled trials are necessary prior to changing the current guidelines regarding patient selection for CRT.

Entities:  

Mesh:

Year:  2009        PMID: 19717847     DOI: 10.1093/eurheartj/ehp368

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  46 in total

Review 1.  Echocardiography, dyssynchrony, and the response to cardiac resynchronization therapy.

Authors:  Cheuk-Man Yu; John E Sanderson; John Gorcsan
Journal:  Eur Heart J       Date:  2010-08-13       Impact factor: 29.983

2.  Effect of cardiac resynchronization therapy in patients without left intraventricular dyssynchrony.

Authors:  Dominique Auger; Gabe B Bleeker; Matteo Bertini; See H Ewe; Rutger J van Bommel; Tomasz G Witkowski; Arnold C T Ng; Lieselot van Erven; Martin J Schalij; Jeroen J Bax; Victoria Delgado
Journal:  Eur Heart J       Date:  2012-01-24       Impact factor: 29.983

Review 3.  Current role of echocardiography in cardiac resynchronization therapy.

Authors:  Donato Mele; Matteo Bertini; Michele Malagù; Marianna Nardozza; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

4.  High-amplitude left ventricular pacing in cardiac resynchronization therapy: an alternative way to increase response rate in non-responders.

Authors:  Halit Zengin; Filiz Akın; Sabri Demircan; Korhan Soylu; Alirıza Erbay; Serkan Yuksel; Murat Meric; Okan Gulel; Mahmut Sahin; Ozcan Yılmaz
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

5.  The effects of dobutamine stress on cardiac mechanical synchrony determined by phase analysis of gated SPECT myocardial perfusion imaging in a canine model.

Authors:  Samaneh Salimian; Bernard Thibault; Vincent Finnerty; Jean Grégoire; François Harel
Journal:  J Nucl Cardiol       Date:  2014-01-09       Impact factor: 5.952

Review 6.  [Cardiac resynchronisation therapy : new data and technical developments].

Authors:  C Butter
Journal:  Herz       Date:  2011-10       Impact factor: 1.443

7.  Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure.

Authors:  Qiong Qiu; Yang-xin Chen; Jing-ting Mai; Wo-liang Yuan; Yu-lin Wei; Ying-mei Liu; Li Yang; Jing-Feng Wang
Journal:  Int J Cardiovasc Imaging       Date:  2014-11-13       Impact factor: 2.357

8.  The potential role of gated myocardial perfusion SPECT imaging in patient selection for cardiac resynchronization therapy.

Authors:  Nina Ajmone Marsan; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2014-08-12       Impact factor: 5.952

9.  Prognostic Role of Right Ventricular Function in Patients With Heart Failure Undergoing Cardiac Resynchronization Therapy.

Authors:  Antonio Rapacciuolo; Stefano Maffè; Pietro Palmisano; Anna Ferraro; Antonella Cecchetto; Antonio D'Onofrio; Francesco Solimene; Paola Musatti; Paola Paffoni; Francesca Esposito; Umberto Parravicini; Alessia Agresta; Giovanni Luca Botto; Maurizio Malacrida; Giuseppe Stabile
Journal:  Clin Cardiol       Date:  2016-07-28       Impact factor: 2.882

Review 10.  Sex and gender differences in myocarditis and dilated cardiomyopathy.

Authors:  DeLisa Fairweather; Leslie T Cooper; Lori A Blauwet
Journal:  Curr Probl Cardiol       Date:  2013-01       Impact factor: 5.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.